Patents by Inventor Cornelis A. Rijnbrand

Cornelis A. Rijnbrand has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • THERAPEUTIC COMPOSITIONS AND METHODS FOR TREATING HEPATITIS B
    Publication number: 20240050463
    Abstract: The invention provides therapeutic combinations and therapeutic methods that are useful for treating Hepatitis B.
    Type: Application
    Filed: November 29, 2022
    Publication date: February 15, 2024
    Applicant: ARBUTUS BIOPHARMA CORPORATION
    Inventors: Andrea CUCONATI, Amy C. H. LEE, Cornelis A. RIJNBRAND, Michael J. SOFIA
  • THERAPEUTIC METHODS FOR TREATING HEPATITIS B
    Publication number: 20220168430
    Abstract: The invention provides therapeutic combinations and therapeutic methods that are useful for treating Hepatitis B and Hepatitis D.
    Type: Application
    Filed: March 19, 2020
    Publication date: June 2, 2022
    Applicant: ARBUTUS BIOPHARMA CORPORATION
    Inventors: Andrzej ARDZINSKI, Andrea CUCONATI, Amy C. H. LEE, Nagraj MANI, Cornelis A. RIJNBRAND, Michael J. SOFIA, Emily P. THI
  • THERAPEUTIC COMPOSITIONS AND METHODS FOR TREATING HEPATITIS B
    Publication number: 20190282604
    Abstract: The invention provides therapeutic combinations and therapeutic methods that are useful for treating Hepatitis B.
    Type: Application
    Filed: January 6, 2017
    Publication date: September 19, 2019
    Applicant: ARBUTUS BIOPHARMA CORPORATION
    Inventors: Andrea CUCONATI, Amy C. H. LEE, Cornelis A. RIJNBRAND, Michael J. SOFIA
  • Antisense antiviral compound and method for treating picornavirus infection
    Patent number: 8329668
    Abstract: The invention provides antisense antiviral compounds and methods of their use and production in inhibition of growth of viruses of the Picornaviridae family and in the treatment of a viral infection. The compounds are particularly useful in the treatment of Enterovirus and/or Rhinovirus infection in a mammal. The antisense antiviral compounds are substantially uncharged, including partially positively charged, morpholino oligonucleotides have a sequence of 12-40 subunits, including at least 12 subunits having a targeting sequence that is complementary to a region associated with viral RNA sequences within a 32 nucleotide region of the viral 5? untranslated region identified by SEQ ID NO:4.
    Type: Grant
    Filed: September 8, 2006
    Date of Patent: December 11, 2012
    Assignee: AVI Biopharma, Inc.
    Inventors: David A. Stein, Cornelis A. Rijnbrand, Patrick L. Iversen, Dwight D. Weller
  • Antisense antiviral compound and method for treating picornavirus infection
    Publication number: 20070129323
    Abstract: The invention provides antisense antiviral compounds and methods of their use and production in inhibition of growth of viruses of the Picornaviridae family and in the treatment of a viral infection. The compounds are particularly useful in the treatment of Enterovirus and/or Rhinovirus infection in a mammal. The antisense antiviral compounds are substantially uncharged, including partially positively charged, morpholino oligonucleotides have a sequence of 12-40 subunits, including at least 12 subunits having a targeting sequence that is complementary to a region associated with viral RNA sequences within a 32 nucleotide region of the viral 5? untranslated region identified by SEQ ID NO:4.
    Type: Application
    Filed: September 8, 2006
    Publication date: June 7, 2007
    Inventors: David Stein, Cornelis Rijnbrand, Patrick Iversen, Dwight Weller